Oil prices slid sharply on Thursday, with the commodity dropping along with other perceived riskier assets after the Federal Reserve hiked U.S. interest rates and as supply issues returned to haunt the market.
Investors remain focused on what the market thinks is an overly hawkish Fed stance
‘Today’s main risk event for financial markets will be the Federal Reserve’: says FXTM analyst
FedEx and Micron sound alarms in late-season reports that suggest a global economic slowdown
All eyes are on the Federal Reserve
H&M tumbles 9% as retailer take a hit
WTI crude hovers at $48 a barrel
There are some BIG names in bear territory right now.
Company buys back $10 billion in stock over quarter
Awaiting FDA review, Medtronic details study of adaptive neurostimulation in Parkinson’s disease
GE HealthCare claims FDA clearance for amyloid imaging software in Alzheimer’s disease
Innovent links cytokine fusion protein to responses in colorectal cancer
FDA scraps adcomm for Applied’s rare disease drug ahead of November decision
Inflammation-focused Upstream set to join growing trickle of biotech IPOs
NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines
Novo Nordisk bets $600M biobucks on NanoVation’s ability to take genetic medicines beyond the liver
Capricor sells Europe rights to DMD therapy for $35M as FDA application approaches
Lumps of coal for Wall Street money managers — again
Stock market will find it hard to rally unless the dollar and bonds calm down
